Novo Nordisk A/S
NVO
Company Profile
Business description
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Contact
Novo Alle 1
Bagsvaerd 2880
DNKT: +45 44448888
E: phak@novonordisk.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
60,000
Novo Nordisk A/S News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.
stocks
Best international companies to own: 2023 Edition
These companies from various corners of the globe are well positioned for the future.
markets
The US market could be set for a decade of underperformance
The US tech bubble has driven the S&P 500's gains over the past 10 years, and here's why the rest of the world may be about to play catch-up.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,906.60 | 69.20 | 0.88% |
| CAC 40 | 8,065.15 | 23.09 | -0.29% |
| DAX 40 | 18,118.32 | 42.69 | -0.24% |
| Dow JONES (US) | 38,386.09 | 146.43 | 0.38% |
| FTSE 100 | 8,147.03 | 7.20 | 0.09% |
| HKSE | 17,746.91 | 95.76 | 0.54% |
| NASDAQ | 15,983.08 | 55.18 | 0.35% |
| Nikkei 225 | 37,934.76 | 306.28 | 0.81% |
| NZX 50 Index | 11,901.08 | 15.16 | -0.13% |
| S&P 500 | 5,116.17 | 16.21 | 0.32% |
| S&P/ASX 200 | 7,637.40 | 61.50 | 0.81% |
| SSE Composite Index | 3,113.04 | 24.41 | 0.79% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Worley Ltd WOR | 16.31 | 0.18 | 1.12% |
| The Star Entertainment Group Ltd SGR | 0.42 | 0.03 | 6.41% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Mesoblast Ltd MSB | 1.09 | 0.16 | 16.67% |
| South32 Ltd S32 | 3.51 | 0.14 | 4.15% |
| Pilbara Minerals Ltd PLS | 3.96 | 0.16 | 4.21% |
| Telstra Group Ltd TLS | 3.66 | 0.02 | 0.55% |
| Northern Minerals Ltd NTU | 0.03 | 0.00 | 6.25% |
| Jupiter Mines Ltd JMS | 0.32 | 0.02 | 5.00% |
| Imugene Ltd IMU | 0.08 | 0.00 | 3.80% |